compound semaglutide and alcohol & Compounded Semaglutide: Safety Considerations – PlexusDx Compounded Semaglutide with B12 |
Description
The results of a phase 2 trial of the triple agonist LY3437943 (Retatrutide) showed 24.2% weight loss at the highest dose (12 mg) in 48 weeks (83)

It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing

Blume LC, Bass CE, Childers SR, Dalton GD, Roberts DC, Richardson JM et al (2013)

Moreover, functional MRI studies have demonstrated impaired connectivity within the default mode network in T2DM patients

Many women in their 40s, 50s, and beyond have worked hard to improve their health, often with the help of GLP-1 medications

The highest dose group achieved average reductions of around 20% of body weight
